Newland Pharmaceutical Co., Ltd. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CNY 184.58 million compared to CNY 172.54 million a year ago. Revenue was CNY 184.58 million compared to CNY 172.54 million a year ago.

Net income was CNY 55.92 million compared to CNY 46.72 million a year ago. Basic earnings per share from continuing operations was CNY 0.28 compared to CNY 0.23 a year ago. Diluted earnings per share from continuing operations was CNY 0.28 compared to CNY 0.23 a year ago.